The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson’s Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Neurochemical Research

• Publication date

  2024-08-27

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11064-024-04226-5PMID 39190122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pathogenesis of Parkinson's disease.

  2024cited by this paper
• Transcriptional Insights of Oxidative Stress and Extracellular Traps in Lung Tissues of Fatal COVID-19 Cases

  2023cited by this paper
• Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine

  2023cited by this paper
• The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies

  2023cited by this paper
• The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function

  2022cited by this paper
• ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis

  2022cited by this paper
• Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations

  2022cited by this paper
• Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.

  2022cited by this paper
• 8-oxoguanine and 8-oxodeoxyguanosine Biomarkers of Oxidative DNA Damage: A Review on HPLC–ECD Determination

  2022cited by this paper
• Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke

  2021cited by this paper
• Carveol Attenuates Seizure Severity and Neuroinflammation in Pentylenetetrazole-Kindled Epileptic Rats by Regulating the Nrf2 Signaling Pathway

  2021cited by this paper
• NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin

  2021cited by this paper
• Microglia regulation of synaptic plasticity and learning and memory

  2021cited by this paper
• Potent Natural Antioxidant Carveol Attenuates MCAO-Stress Induced Oxidative, Neurodegeneration by Regulating the Nrf-2 Pathway

  2020influential reference
• Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury

  2020cited by this paper
• Modulators of microglia activation and polarization in ischemic stroke

  2020cited by this paper
• Benzimidazole Containing Acetamide Derivatives Attenuate Neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration

  2020cited by this paper
• Natural volatile oils derived from herbal medicines: A promising therapy way for treating depressive disorder.

  2020cited by this paper
• Computational and Pharmacological Evaluation of Carveol for Antidiabetic Potential

  2020cited by this paper
• Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease

  2020cited by this paper
• The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.

  2019cited by this paper
• Inflammation, Infectious Triggers, and Parkinson's Disease

  2019influential reference
• Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway

  2019cited by this paper
• Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach

  2019cited by this paper
• Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPAR&ggr;/Nrf2/NF‐&kgr;B signaling pathway

  2019cited by this paper
• The endotoxin hypothesis of neurodegeneration

  2019cited by this paper
• NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches

  2018cited by this paper
• MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

  2018cited by this paper
• Drug Repurposing in Parkinson’s Disease

  2018cited by this paper
• Inhibition of NRF2 signaling and increased reactive oxygen species during embryogenesis in a rat model of retinoic acid‐induced neural tube defects

  2018cited by this paper
• Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

  2017cited by this paper
• Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice

  2017cited by this paper
• The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

  2017cited by this paper
• The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

  2017cited by this paper
• Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.

  2017cited by this paper
• Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson’s Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway

  2017cited by this paper
• Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies.

  2015cited by this paper
• Oxidative stress and Parkinson’s disease

  2015cited by this paper
• Toward clinical application of the Keap1-Nrf2 pathway.

  2013cited by this paper
• Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.

  2013cited by this paper
• Nrf2 participates in depressive disorders through an anti-inflammatory mechanism.

  2013cited by this paper
• The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism

  2012cited by this paper
• Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

  2010cited by this paper
• A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

  2008cited by this paper
• Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha

  2007cited by this paper
• Effect of Immunomodulation With Human Interferon-&bgr; on Early Functional Recovery From Experimental Spinal Cord Injury

  2007cited by this paper
• The pathogenesis of cell death in Parkinson's disease

  2006cited by this paper
• Publisher's Note

  2003cited by this paper

• Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases

  2026cites this paper
• Mitochondrial oxidative stress to PANoptosis: Current evidence and therapeutic implications for neurological diseases.

  2026cites this paper
• Synthesis, Characterization, Molecular Dynamic Simulation and Neuroprotective Effects of Synthetic Isoxazolone Derivatives in Ethanol-Induced Neurodegeneration.

  2025cites this paper
• Neuroinflammation-mediated white matter injury in Parkinson's disease and potential therapeutic strategies targeting NLRP3 inflammasome.

  2024cites this paper